August 31, 2001
Roche and the Brazilian Ministry of Health have reached an agreement on the conditions for the supply of the HIV medication Viracept (nelfinavir) and the Brazilian Ministry of Health has agreed to honour the patent for the drug. The agreement secures the supply of the much needed AIDS medication during 2002 at substantially reduced prices for Brazilians treated within the Government programme. This agreement was reached following recent negotiations between the Ministry of Health and Roche.
The President of Roche Brazil, Ernest Egli stated: "We are pleased that after lengthy negotiations we have reached this agreement with the Minister of Health which is acceptable for both parties. In achieving this outcome we can continue to make a very special effort to collaborate with the exemplary AIDS programme of the Brazilian Government."
The price agreed for 2002 represents an additional reduction of 40%. In addition, Roche is starting local production of the drug in Brazil early next year. The shift to local production of Viracept by Roche in Brazil is made possible by the volume of the tender purchase agreed with the Brazilian Government. With this agreement Roche continues to demonstrate its commitment to working in partnership with the Brazilian Government in their well-established fight against HIV and AIDS.
Headquartered in Basel, Switzerland, Roche is one of the world's leading research-oriented healthcare groups in the fields of pharmaceuticals, diagnostics and vitamins. Roche's products and services address prevention, diagnosis and treatment of diseases, thus enhancing well-being and quality of life.
FAIR USE NOTICE: This page contains copyrighted material the use of which has not been specifically authorized by the copyright owner. Global Policy Forum distributes this material without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. We believe this constitutes a fair use of any such copyrighted material as provided for in 17 U.S.C § 107. If you wish to use copyrighted material from this site for purposes of your own that go beyond fair use, you must obtain permission from the copyright owner.
